Common Contracts

ICON and ACRONET Sign Alliance Agreement in Japan

Alliance Agreement • July 5th, 2011

• Contract Type
  Alliance Agreement
• Filed
  July 5th, 2011

Commenting on the alliance, Alan Morgan, ICON’s Group President, Clinical Research Services, said, “Japan is an important centre for clinical research and ICON has a well established presence there. Recent changes in the regulatory landscape mean that an increasing number of Japanese based pharmaceutical companies are looking to run development projects on both a domestic and pan regional basis. The alliance between ICON and ACRONET will benefit clients, who can be assured of a wider range of quality drug development services alongside truly global expertise.”